Clinical Trial Update: Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Cunermuspir for safety and efficacy in neuralgia and myalgia; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgia
• Neuralgia

Drugs mentioned

• Cunermuspir

Snippet

Sponsor: Mitosynergy LLC | Conditions: Neuralgia, Myalgia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-04-20